66 -- OMNIGRID MICROARRAYER SYSTEM

Notice Date

September 21, 2001

Contracting Office

Department of Health and Human Services, Food and Drug Administration, Jefferson Laboratories, National Center for Toxicological Research, Attn: Contracts 3900 NCTR Road, Jefferson, AR, 72079

ZIP Code

72079

Solicitation Number

R-1011-00-1

Response Due

September 27, 2001

Point of Contact

Patsy Scott, Contract Specialist, Phone (870) 543-7577, Fax (870) 543-7990, Email pscott@nctr.fda.gov -- Priscella Sullivan, Contracting Officer, Phone (870) 543-7271, Fax (870) 543-7990, Email psullivan@nctr.fda.gov

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement Constitutes the only solicitation. This is a Request for Quotation (RFQ); a written solicitation will not be issued. The Food and Drug is soliciting for a GeneMachines or equal, systems description as follows: (1) OmniGrid microarrayer system with the minimum requirements: 1. Must be able to print 30,000 spots/slide onto 100 slides in 10 hours (using 48 pins). 2. Print head must support up to 48 pins. 3. Must have 100 slide capacity. 4. Must have 74 sample plate capacity. 5. Must have server arm for unattended run times of up to 14 hr. 6. Must have automated plate de-lidding function. 7. Must have +/-2.5 micron positional accuracy (resolution and error limit) to ensure spot consistency. 8. Must have industrial grade motors and components. 9. Must have modular design for easy service access and future upgrade additions. 10. Must be able to use up to 20 microplate brands. 11. Must be able to support multiple pin manufactures. 12. Must be completely enclosed for humidity/desiccant control and have HEPA filtration built into the system to minimize sample evaporation and dust contamination. 13. Must be capable of removing humidity from the enclosed environment. 14. Must have software for sample tracking compatible with Axon, GSI-Luminomics (Packard) and other microarray scanners. 15. Software must allow random access of samples. 16. Software must allow protocol and array design flexibility using Graphic User Interface. 17. Software must allow control of Z-axis acceleration rate. 18. Must have 3 levels of security access to software. 19. Must provide lifetime support by in-house biology staff and microarray team. 20.Must be able to control array placement on slide. 21. Must be able to control size and shape of arrays, and samples per array. 22. Must allow control of printing operation including sample blotting feature, test print feature, customizable Z-axis printing speed, and pause and restart control for print runs. 23. Must allow total flexibility to create printing pin cleaning procedure including customizable combination of sonication, water fluid was with peristaltic pump, and vacuum dry. fob Destination within 60 days after award of a purchase order. Interested offeror?s shall submit descriptive literature along with their cost quotation. Offerors who are offering other than the GeneMachines system shall submit descriptive literature in sufficient detail as to demonstrate that the system offered meets or exceeds the GeneMachiines specifications. Award will be made to the vendor who submits the lowest price system that meets all technical specifications. The Government may make its decision on the basis of initial quotations received and not have discussions. Therefore each initial quotation should contain the offeror?s best terms from both a price and technical standpoint. This Request for Quotation number R-1011-00-1. APPLICABILITY OF FAR PROVISIONS: the following Federal Acquisition Regulation (FAR) provisions and clauses apply to this solicitation and are incorporated by references. FAR 52.212-1 Instruction to Offerors -- Commercial Items. Offer must include a completed copy of FAR provisions 52.212-3 Offeror Representations and Certifications ? Commercial Items with their offer. FAR provision 52.232-18 Availability of Funds. FAR Provision 52.212-4 Contract Terms and Conditions ? Commercial Items. FAR 52.212-5 Facsimile Quotations. FAR 52.212-5, Contract Terms and Conditions Required to Implement Statues or Executive Orders ? Commercial Items, for paragraphs 1, b and c, only the following clauses apply to this requisition: 52.233-3, Protest after Award (31 U.S.C. 3553); 52.203-6, Restrictions on Subcontractor Sales to the Government, with Alternate I (41 U.S.C. 253g and 10 U.S.C. 2402); 52.219-8.Utilization of Small Business Concerns (15 U.S.C. 637(d)(2) and (3)); 52.222-21, Prohibition of Segregated Facilities (FEB 1999); 52.222-26, Equal Opportunity (E.O. 11246); 52.222-35, Affirmative Action for Disabled Veterans and Veterans of The Vietnam Era (38 U.S.C. 4212); 52.222-36, Affirmative Action for Workers with Disabilities (29 U.S.C. 793); 52.222-37, Employment Reports on Disabled Veterans and Veterans of the Vietnam Era (38 U.S.C. 4212); 52.222-19, Child Labor ? Cooperation with Authorities and Remedies (E.O. 13126); 52.225-1, Buy American Act ? Balance of Payments Program ? Supplies(41 U.S.C. 10a ? 10d) and ; 52.232-4, Payment by Electronic Funds transfer-Other than Central Contractor Registration (31U.S.C. 3332). Offers are due in this office no later than September 27, 2001. The point of contact for this requirement is Patsy Scott; telephone (870) 543-7577 and fax number is (870) 543-7990. Submit offers to the National Center for Toxicological Research, HFT-322, 3900 NCTR Road, Jefferson, AR 72079-9502, Attention Patsy Scott. An official authorized to bind the Offeror must sign the terms and conditions of the offer. Offerors that fail to finish required representations and certifications, or reject the terms and conditions of the solicitation, may be excluded from consideration. all responsible sources may submit a quote, which shall be considered. See numbered Note 22.=20

Web Link

Visit this URL for the latest information about this (http://www.eps.gov/spg/HHS/FDA/NCTR/R-1011-00-1/listing.html)

Record

Loren Data Corp. 20010925/66SOL005.HTM (D-264 SN50Y405)